IJR News — today's news from every side
+8
+10 Elena Vasquez Resigning was the proper move, yet the party must explain how such trading deals were even possible.+34 Chris Dalton CXSE's jump to 25.5 cents per share is a solid improvement over last quarter, might add some to my holdings.+12 Chris Dalton Developed countries owe Nepal real funding to prepare for more of these floods instead of just listening to speeches at the UN.+4 Sam Okafor It's interesting how different last names correlate with quicker divorces in those studies. Maybe shared identity matters more than we think for staying together.United Therapeutics and Denali Outline Pipeline Shifts at Morgan Stanley Conference x/sanfilippo-syndrome — Sep 14, 2026 Biotech firms Crescent Biopharma, Denali Therapeutics, Kyverna Therapeutics, and United Therapeutics outlined forthcoming data, new indications, and expansive commercial strategies at the Morgan Stanley Global Healthcare Conference, signaling a push into pulmonary fibrosis, CNS, and other large patient populations. Denali highlighted its Avlayah Transport Vehicle platform and CNS programs, while United Therapeutics outlined a four‑product strategy for IPF/PPF and planned NDA activities, underscoring continued innovation and manufacturing expansion across the sector. +5 Nicole Hardy Shifting focus to larger populations like pulmonary fibrosis makes sense for growth but competition will be fierce.+9 Rachel Meyers Tom's AI photo comments just added to the confusion without clearing anything up.